Mexico Single Cell Sequencing Market (2025-2030)
The Mexico Single Cell Sequencing Market was valued at $14 Million in 2025 and projected to reach to $22.9 Million by 2030, representing a compound annual growth rate of 10.3%. Mexico's single cell sequencing market is poised for sustained growth as healthcare institutions prioritize advanced genomic technologies for research and clinical applications.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Mexico Single Cell Sequencing Market Trends and Insights
- This 10.3% compound annual growth rate reflects Mexico's increasing adoption of advanced genomic technologies in research institutions and clinical diagnostics.
- Mexico is positioning itself as a growing hub for precision medicine and personalized healthcare within North America, driven by rising investments in biotechnology infrastructure and academic research capabilities. The expansion of Mexico's single cell sequencing market is supported by growing collaborations between Mexican research centers and international genomics organizations.
- Mexico's healthcare sector is increasingly recognizing the value of single cell analysis for cancer research, immunology, and developmental biology applications.
- Between 2025 and 2030, Mexico is expected to see enhanced laboratory capacity and greater accessibility to sequencing platforms, enabling broader adoption across both public and private research institutions..
Key Market Statistics
- CAGR (2025-2030) 10.3% CAGR
- Market Size, 2025 ~USD 14 Million
- Forecast, 2030 ~USD 22.9 Million
- Country Mexico
Mexico Single Cell Sequencing Market Overview
Market Valuation Growth :
Mexico's single cell sequencing market is valued at $14.0 million in 2025 and is projected to reach $22.9 million by 2030, representing a robust 10.3% CAGR over the forecast period.
Research Institution Expansion :
Leading Mexican research institutions and universities are increasingly investing in single cell sequencing technologies, driving adoption across genomics and molecular biology research programs.
Precision Medicine Adoption :
Mexico is emerging as a growing hub for precision medicine and personalized healthcare, with clinical diagnostics centers integrating single cell sequencing for improved patient outcomes and targeted treatments.
Technology Infrastructure Development :
Investment in advanced genomic infrastructure and bioinformatics capabilities across Mexican healthcare facilities is accelerating the deployment of single cell sequencing platforms and analytical tools.
Mexico Single Cell Sequencing Market Dynamics
- The 10.3% CAGR reflects increasing recognition of single cell sequencing's value in understanding cellular heterogeneity and disease mechanisms.
- Government support for precision medicine initiatives and growing collaborations between Mexican research centers and international genomics organizations are expected to drive market expansion.
- Additionally, rising investments in bioinformatics infrastructure and talent development will enhance Mexico's capacity to adopt and implement single cell sequencing technologies across academic and clinical settings..
Related Ecosystem
Advanced Genetic Sequencing
- Polymerase Chain Reaction (PCR)
- Reagents
- Assay Kits
- Bioinformatics
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Agilent Technologies, Inc.
- Qiagen N.V.
- Danaher Corporation
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- Mexico's single cell sequencing market is valued at $14.0 million in 2025 and will reach $22.9 million by 2030, representing a 10.3% CAGR.
- Mexico is strengthening its position as a precision medicine leader in North America through increased biotechnology investments and research infrastructure development.
- Growing academic-industry partnerships in Mexico are accelerating the adoption of single cell sequencing for cancer, immunology, and developmental biology research.
- Mexico's healthcare modernization initiatives are expanding laboratory capacity and accessibility to advanced sequencing technologies across research institutions.
Single Cell Sequencing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SERVICES (Offering) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 12.2% from 2025 to 2030 |
| Largest Segment | PRODUCTS (Offering) |
| Market Size Base Year (Billions) | ~USD 1.95 (2025) |
| Revenue Forecast (Billions) | ~USD 3.46 (2030) |
| Segments Covered | Offering, Type, End User, Sequencing Type, Application, Workflow |
Mexico Single Cell Sequencing Market Report Segmentation
6 segment dimensions are covered across the global market.
By Offering
- Products
- Services
By Type
- Basic & Translational Research
- Cancer Research
- Cell Sorters
- Consumables
- Data Analysis & Bioinformatics Services
- Data Storage & Management Software
- Drug Discovery & Development
- Instruments
- Lcm Instruments
- Library Preparation Services
- Microbiology & Infectious Diseases
- Microfluidic Instruments
- Neurology & Brain Research
- Organ Development & Regenerative Medicine
- Other Pre-Sequencing Instruments
- Pcr Instruments
- Pre-Sequencing Instruments
- Pre-Sequencing Reagents & Kits
- Pre-Sequencing Services
- Sample Preparation, Single-Cell Isolation, And Enrichment Services
- Sequencing Platforms
- Sequencing Reagents & Kits
- Sequencing Services
- Software
- Software Tools
- Stem Cell & Developmental Biology
By End User
- Academic & Research Institutes
- Biotechnology & Pharmaceutical Companies
- Cros
- Hospitals & Clinical Laboratories
- Pharmaceutical & Biopharmaceutical Companies
By Sequencing Type
- Other Single-Cell Sequencing Types
- Scatac-Seq
- Scdna-Seq
- Scrna-Seq
By Application
- Diagnostic & Clinical Applications
- Research Applications
By Workflow
- Data Analysis & Interpretation
- Pre-Sequencing
- Sequencing
MEXICO: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER,2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTES | 1.64 | 1.83 | 1.94 | 2.13 | 2.37 | 2.7 | 3.14 | 3.75 | 14 |
| BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES | 1.47 | 1.65 | 1.76 | 1.93 | 2.17 | 2.48 | 2.91 | 3.49 | 14.7 |
| HOSPITALS & CLINICAL LABORATORIES | 0.95 | 1.04 | 1.09 | 1.17 | 1.28 | 1.43 | 1.63 | 1.9 | 11.8 |
| TOTAL | 4.06 | 4.52 | 4.79 | 5.23 | 5.82 | 6.61 | 7.69 | 9.14 | 13.8 |
MEXICO: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTES | 5.88 | 5.86 | 5.91 | 6.21 | 6.73 | 7.47 | 8.47 | 9.75 | 10.5 |
| CROS | 1.36 | 1.34 | 1.33 | 1.37 | 1.46 | 1.6 | 1.78 | 2.02 | 8.8 |
| HOSPITALS & CLINICAL LABORATORIES | 2.77 | 2.74 | 2.75 | 2.87 | 3.08 | 3.4 | 3.82 | 4.37 | 9.7 |
| PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES | 3.98 | 3.98 | 4.03 | 4.25 | 4.62 | 5.14 | 5.85 | 6.75 | 10.9 |
| TOTAL | 14 | 13.9 | 14 | 14.7 | 15.9 | 17.6 | 19.9 | 22.9 | 10.3 |
Target Audience
- Genomics Equipment Manufacturers : Manufacturers need Mexico-specific market data to assess demand for single cell sequencing platforms, identify key customer segments, and develop localized sales and distribution strategies.
- Diagnostic Service Providers : Clinical laboratories and diagnostic centers require market insights to evaluate investment opportunities in single cell sequencing capabilities and understand competitive positioning in Mexico.
- Research Institutions & Universities : Academic and research organizations need market intelligence to justify funding requests, benchmark technology adoption rates, and identify collaboration opportunities within Mexico's research ecosystem.
- Healthcare Investors & Venture Capital : Investment firms focused on precision medicine and genomics require detailed Mexico market data to identify promising startups, assess growth potential, and make informed funding decisions.
- Pharmaceutical & Biotech Companies : Pharma and biotech firms need Mexico market insights to evaluate opportunities for precision medicine applications, personalized drug development, and clinical trial expansion in the region.
Reasons to Buy this Report
- Market Size & Growth Projections : Access precise valuation data for Mexico's single cell sequencing market with detailed forecasts through 2030, enabling accurate investment planning and resource allocation decisions.
- Competitive Landscape Analysis : Understand key players, market dynamics, and competitive positioning specific to Mexico's genomics sector to identify partnership and expansion opportunities.
- Regional Adoption Trends : Gain insights into Mexico-specific adoption patterns across research institutions and clinical diagnostics centers to tailor product offerings and market entry strategies.
- Investment & Growth Drivers : Identify key growth catalysts including government initiatives, infrastructure investments, and precision medicine adoption to inform strategic business decisions in Mexico.
- Regulatory & Market Environment : Understand Mexico's healthcare regulatory framework, reimbursement landscape, and market barriers to develop compliant and commercially viable market strategies.
Frequently asked questions
What is the current market size of single cell sequencing in Mexico?
Mexico's single cell sequencing market is valued at $14.0 million in 2025 and is projected to grow to $22.9 million by 2030.
What is the expected growth rate for Mexico's single cell sequencing market?
Mexico's single cell sequencing market is expected to grow at a compound annual growth rate (CAGR) of 10.3% from 2025 to 2030.
Which research applications are driving single cell sequencing adoption in Mexico?
Cancer research, immunology, and developmental biology are the primary applications driving single cell sequencing adoption in Mexico's research institutions.
How is Mexico's healthcare sector supporting single cell sequencing growth?
Mexico is supporting growth through increased biotechnology infrastructure investments, academic-industry partnerships, and healthcare modernization initiatives that expand laboratory capacity.
What role does Mexico play in North America's genomics landscape?
Mexico is positioning itself as a growing precision medicine hub within North America, leveraging its research capabilities and strategic collaborations with international genomics organizations.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global single-cell sequencing market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single cell sequencing market. The secondary sources used for this study The secondary sources used for this study include the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), the International Clinical Cytometry Society (ICCS), the International Society for Advancement of Cytometry (ISAC), the National Institutes of Health (NIH), the Organisation for Economic Co-operation and Development (OECD), and the Society for Laboratory Automation and Screening (SLAS); Corporate and Regulatory Filings, Annual Reports, Sec Filings, Investor Presentations, and Financial Statements; Business Magazines & Research Journals; Press Releases, MarketsandMarkets Analysis. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global single-cell sequencing market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (personnel from, pharmaceutical & and biotechnology companies, hospitals & diagnostic laboratories, academic & research institutes, and contract research organization) and supply side (C-level and D-level executives, product managers, and marketing and sales managers of key manufacturers, distributors, and channel partners, among others, across six major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. Approximately 70% of primary interviews were conducted with supply-side representatives, while demand-side participants accounted for the remaining share. This preliminary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-cell sequencing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Single Cell Sequencing Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the overall market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.
Market Definition
Single-cell sequencing (SCS) is a genomic technology that allows researchers to study the genetic material of individual cells. Unlike traditional sequencing methods that analyze bulk cell populations, single-cell sequencing helps identify differences between individual cells, providing a clearer understanding of cell functions, disease mechanisms, and treatment responses. The scope of the single-cell sequencing market includes a wide range of products and services used across the entire single-cell workflow. This covers pre-sequencing instruments and consumables (such as cell isolation tools and library preparation kits), sequencing instruments and consumables, and software for analyzing single-cell data. The market also includes services provided by third parties across pre-sequencing, sequencing, and data analysis stages. The market also studies various sequencing types, including single-cell RNA sequencing (scRNA-seq), single-cell DNA sequencing (scDNA-seq), and single-cell ATAC sequencing (scATAC-seq), among others. These technologies are widely used in basic and translational research, drug discovery, and clinical applications, especially in cancer, neurological, and infectious diseases. End users of these solutions studied in the report include academic and research institutions, pharmaceutical and biotechnology companies, hospitals and diagnostic labs, and contract research organizations (CROs).
Stakeholders
- Academic & Research Institutes
- Single-cell Sequencing Assay & Reagent Manufacturers, Vendors, and Distributors
- Contract Research Organizations (CROs)
- Single-cell Sequencing Service & Software Providers
- Diagnostics Companies
- Market Research & Consulting Firms
- Pharmaceutical & Biotechnology Companies
- Regulatory Agencies
- Venture Capitalists
- Government organizations
- Contract Development & Manufacturing Organizations (CDMOs)
- Hospitals and Diagnostic Laboratories
Report Objectives
- To define, describe, and forecast the global single-cell sequencing market based on offering, product type, product workflow, product end user, service type, service end user, sequencing type, application, and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six central regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To profile the key players in the global single-cell sequencing market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments such as acquisitions, product launches & approvals, expansions, agreements, partnerships, and collaborations in the single-cell sequencing market
- To benchmark players in the single-cell sequencing market using the “Company Evaluation Matrix” framework, which analyzes market players based on various parameters, including product portfolio, geographic reach, and market share
Available Customizations
With the given market data, MarketsandMarkets offers customizations to meet the company’s needs. The following customization options are available for the report:
Geographical Analysis
- Further breakdown of the Rest of Europe’s single-cell sequencing market, by country
- Further breakdown of the Rest of Asia Pacific’s single-cell sequencing market, by country
- Further breakdown of the Rest of Latin America’s single-cell sequencing market, by country
- Further breakdown of the Rest of the Middle East’s single-cell sequencing market, by country
Company Information
- Detailed analysis and profiling of additional market players (up to five)
Segment Analysis
- Further breakdown of the other technologies into subsegments
- Cross-segment analysis
Get the Full Single Cell Sequencing Market Report
Full forecast, segment splits, and company analysis for all Single Cell Sequencing Market.
- US Single Cell Sequencing Market
- Canada Single Cell Sequencing Market
- UK Single Cell Sequencing Market
- Germany Single Cell Sequencing Market
- France Single Cell Sequencing Market
- Italy Single Cell Sequencing Market
- Spain Single Cell Sequencing Market
- China Single Cell Sequencing Market
- Japan Single Cell Sequencing Market
- India Single Cell Sequencing Market
- South Korea Single Cell Sequencing Market
- Australia Single Cell Sequencing Market
- Brazil Single Cell Sequencing Market
- Rest Of Europe Single Cell Sequencing Market
- Rest Of Asia Pacific Single Cell Sequencing Market
- Rest Of Latin America Single Cell Sequencing Market
- Ksa Single Cell Sequencing Market
- Other GCC Countries Single Cell Sequencing Market
- UAE Single Cell Sequencing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
